Publikationen, an denen er mitarbeitet Peter Clemmensen (2)

2016

  1. Empagliflozin and progression of kidney disease in type 2 diabetes

    New England Journal of Medicine, Vol. 375, Núm. 4, pp. 323-334

2015

  1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes

    New England Journal of Medicine, Vol. 373, Núm. 22, pp. 2117-2128